| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/12/1995 | EP0662132A1 Self-assembling recombinant papillomavirus capsid proteins |
| 07/12/1995 | EP0662130A1 A method of producing hepatocyte growth factor and a cell line |
| 07/12/1995 | EP0662090A1 Peptide inhibitors of mitogenesis and motogenesis |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0662076A1 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity |
| 07/12/1995 | EP0662073A1 Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent |
| 07/12/1995 | EP0662003A1 Oligonucleotide modulation of cell adhesion |
| 07/12/1995 | EP0661977A1 Treatment of colorectal cancer |
| 07/12/1995 | EP0661969A1 Use of taxol for treating lymphomas and breast cancer |
| 07/12/1995 | EP0567586B1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/12/1995 | EP0526537B1 5-benzyl barbiturate derivatives |
| 07/12/1995 | EP0316319B1 Production and use of non-glycosylated IL-6 |
| 07/12/1995 | CN1104907A Medicine for curing tumour |
| 07/11/1995 | US5432190 Pharmaceutical compositions containing triazoles and method of treating estrogen-dependent diseases |
| 07/11/1995 | US5432171 Water soluble texaphyrin metal complexes for viral deactivation |
| 07/11/1995 | US5432168 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/11/1995 | US5432163 Treating inflammatory, autoimmune disorders |
| 07/11/1995 | US5432157 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof |
| 07/11/1995 | US5430935 Method for repairing a combustion chamber assembly |
| 07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| 07/10/1995 | EP0669918A4 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them. |
| 07/08/1995 | CA2139612A1 Novel inhibitor |
| 07/06/1995 | WO1995018228A1 Human circulating cytokine cc-1 |
| 07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
| 07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
| 07/06/1995 | WO1995018223A1 Gene expression control |
| 07/06/1995 | WO1995018138A1 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug |
| 07/06/1995 | WO1995018120A1 [4-(1,2-epoxycyclohexanyl) but-3-en-1-ynyl] aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
| 07/06/1995 | WO1995018091A1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 07/06/1995 | WO1995017908A1 Method for selective methionine starvation of malignant cells in mammals |
| 07/06/1995 | WO1995017902A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based on it with adaptogenic and immunomodulating properties |
| 07/06/1995 | WO1995017901A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | WO1995017888A1 Phenylmethyl hexanamides, and the use thereof |
| 07/06/1995 | WO1995017887A1 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/06/1995 | WO1995017876A2 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
| 07/06/1995 | WO1995011984A3 Recombinant adenoviral vector and methods of use |
| 07/06/1995 | CA2180262A1 Method for selective methionine starvation of malignant cells in mammals |
| 07/06/1995 | CA2180260A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | CA2180009A1 ¬4-(1,2-epoxycyclohexanyl) but-3-en-1-ynyl| aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
| 07/06/1995 | CA2179638A1 Human circulating cytokine cc-1 |
| 07/06/1995 | CA2155095A1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 07/05/1995 | EP0661261A1 Phenyl or phenylalkyl substituted naphtalene derivatives having retinoid-like activity as well as anti-tumor activities |
| 07/05/1995 | EP0661259A1 Substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity |
| 07/05/1995 | EP0661258A1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses |
| 07/05/1995 | EP0661061A2 Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment |
| 07/05/1995 | EP0660936A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 07/05/1995 | EP0660824A1 1,2 DIHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3 DIONE AND THEIR USE AS ANTICANCER AGENTS |
| 07/05/1995 | EP0660821A1 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
| 07/05/1995 | EP0660723A1 Vp6 encapsulated drug delivery. |
| 07/05/1995 | EP0660712A1 Transcutaneous in vivo activation of photosensitive agents in blood |
| 07/05/1995 | EP0556310B1 Quinazolines derivatives for enhancing antitumor activity |
| 07/05/1995 | CN1104831A Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
| 07/05/1995 | CN1104682A Strain of streptomyces lavendofoliae DKRS and method for producing aclacinomycins A,B,Y and aglycones using same |
| 07/04/1995 | US5430148 Antiproliferative quinazolines |
| 07/04/1995 | US5430067 Dihydroanthraquinonecarboxylic acids |
| 07/04/1995 | US5430057 Parenteral busulfan for treatment of malignant disease |
| 07/04/1995 | US5430050 Hispidospermidin |
| 07/04/1995 | US5430026 2'-deoxy-2',2'-difluoro (4-substituted pyrimidine) nucleosides, bicyclic derivatives,pharmaceutical compositions, and synthetic precursors |
| 07/04/1995 | CA2138000A1 Retinoid-like compounds |
| 07/04/1995 | CA2137997A1 Retinoid-like compounds |
| 07/04/1995 | CA1336166C Further improvements relating to drug delivery systems |
| 06/29/1995 | WO1995017507A1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB PLAYS A ROLE |
| 06/29/1995 | WO1995017423A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | WO1995017383A1 Indole derivatives as anti-estrogens |
| 06/29/1995 | WO1995017202A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 06/29/1995 | WO1995017198A1 A novel tumor suppressor gene |
| 06/29/1995 | WO1995017197A1 Vitamin d3 analogues and pathway to mediate disorders |
| 06/29/1995 | WO1995017187A1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin |
| 06/29/1995 | WO1995017182A1 Protein kinase c inhibitors |
| 06/29/1995 | WO1995017181A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
| 06/29/1995 | WO1995017093A1 New cryptophycins |
| 06/29/1995 | WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η? |
| 06/29/1995 | WO1995014085A3 A method for detection of alterations in the dna mismatch repair pathway |
| 06/29/1995 | DE4344661A1 New citronellyl, geranyl, farnesyl, phytyl or iso-phytyl ester cpds |
| 06/29/1995 | CA2187296A1 Indole derivatives as anti-estrogens |
| 06/29/1995 | CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma. |
| 06/29/1995 | CA2179597A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | CA2179490A1 New cryptophycins |
| 06/29/1995 | CA2179288A1 Vitamin d3 analogues and pathway to mediate disorders |
| 06/29/1995 | CA2179196A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 06/29/1995 | CA2178745A1 A novel tumor suppressor gene |
| 06/29/1995 | CA2155098A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
| 06/28/1995 | EP0659752A1 Novel substance dc114-a1 |
| 06/28/1995 | EP0659439A2 Immunoconjugates |
| 06/28/1995 | EP0659435A1 Injectable ready-to-use solutions containing an antitumour anthracycline glycoside |
| 06/28/1995 | EP0659419A1 2-Phenyl-3-azoylthiophenes for inhibiting breast disorders |
| 06/28/1995 | EP0659407A1 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |
| 06/28/1995 | EP0659213A1 Growth hormone antagonists |
| 06/28/1995 | EP0659212A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 06/28/1995 | EP0659209A1 Cancer therapy utilizing malignant cells |
| 06/28/1995 | EP0659182A1 Piperazine derivatives and salts thereof |
| 06/28/1995 | EP0659085A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 06/28/1995 | EP0521897B1 Idiotypic vaccination against b cell lymphoma |
| 06/28/1995 | EP0497809B1 1,4-bis(alkylamino)-2,3-diaza-anthracene-9,10-diones |
| 06/28/1995 | EP0470965B1 Preparation of rhenium phosphonate therapeutic agents |
| 06/28/1995 | EP0439540B1 Antibody conjugates with two or more covalently linked fc regions |
| 06/28/1995 | CN1104411A Ornithine decarboxylase inhibiting cyclic aminooxy compounds |
| 06/28/1995 | CN1104112A Anal fistula eliminating medicine |
| 06/27/1995 | US5428175 Antitumor agent; antimicrobial agent; side effect reduction |
| 06/27/1995 | US5428154 Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions |